Quantitative detection of tumor M2-PK in serum and plasma

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2753-2757

  Hugo, F ^a   Fischer, G ^b   Eigenbrodt, E ^c  

^a KRANKENHAUS NORDWEST   (Germany)

^b Reinhard Nieter Krankenhaus Stadtische Kliniken gGmbH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Routine diagnostic; Tumor M2 PK; Tumor markers

Indexed keywords

CITRIC ACID; DIMER; EDETIC ACID; GLYCOLYTIC ENZYME; HEPARIN; ISOENZYME; PYRUVATE KINASE; TETRAMER; TUMOR MARKER;

BLOOD LEVEL; CENTRIFUGE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; TEMPERATURE; TUMOR CELL;

ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUNG NEOPLASMS; LYMPHOCYTES; PYRUVATE KINASE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032801509     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H and Friis R: Double Role for Pyruvate Kinase Type M2 in Expansion of Phosphometabolite Pools Found in Tumor Cells. Critical Reviews in Oncogenesis 3(1,2): 91-115, 1992.
2. Ibsen K, Orlando RA, Garrat K, Hernandez N, Giorlando S and Nungaray G: Expression of Multimolecular Forms of Pyruvate Kinase in Normal, Benign, and' Malignant Human Breast Tissue. Cancer Res 42: 888-892, 1982.
3. Board M, Humm S and Newsholme EA: Maximum Activities of Key Enzymes of Glycolysis, Glutaminolysis, Pentose Phosphate Pathway and Tricarboxylic Acid Cycle in Normal, Neoplastic and Suppressed Cells. Biochem J 265: 503-509, 1990.
4. Eigenbrodt E, Gerbracht U, Mazurek S, Presek P and Friis R: Carbohydrate Metabolism and Neoplasia: New Perspectives for Diagnosis and Therapy. In: Biochemical and Molecular Aspects of Selected Cancers, Vol. II, T.G. Pretlow and T.P. Pretlow (ed.), Academic Press Inc, New York, pp. 311-385, 1994.
5. Eigenbrodt E, Basenau D, Holthusen S, Mazurek S and Fischer G: Quantification of Tumor Type M2 Pyruvate Kinase (Tu M2-PK) in Human Carcinomas. Anticancer Res 17: 3153-5156, 1997.
6. Oremek GM, Eigenbrodt E, Rädle J, Zeuzem S and Seiffert UB: Value of the Serum Levels of the Tumor Marker Tu M2-PK in Pancreatic Cancer. Anticancer Res 17: 3031-3034, 1997.
7. Scheefers-Borchel U, Scheefers H, Michel A, Will H, Fischer G, Basenau D, Dahlmann N, Laumen R, Mazurek S, Eigenbrodt E: Quantitative determination (ELISA) of pyruvatkinase type tumor M2. In: Current Tumor Diagnosis, Applications, Clinical Relevance, Research-trends. R. Klapdor (ed.), W. Zuckschwerdt Verlag GmbH, München, pp. 365-368, 1994.
8. Brinck U, Eigenbrodt E, Oehmke M, Mazurek S and Fischer G: L- and M2- Pyruvate Kinase Expression in Renal Cell Carcinomas and their Metastases. Virch Arch 424: 177-185, 1994.
9. Hacker HJ, Steinberg P and Bannasch P: Pyruvate Kinase Isoenzyme Shift from L-Type to M2-Type is a Late Event in Hepatocarcinogenesis Induced in Rats by a Choline-Deficient/DL-Ethionine-Supplemented Diet. Carcinogenesis 19: 99-107, 1998.
10. Bhakdi S, Greulich S, Muhly M, Eberspächer B, Becker H, Thiele A, and Hugo F: Potent Leukocidal Action of Escherichia coli Hemolysin Mediated by Permeabilization of Target Cell Membranes. J Exp Med 169: 737-754, 1989.
11. Bhakdi S, Muhly M, Mannhardt U, Hugo F, Klapettek K, Mueller-Eckhardt C, and Roka L: Staphylococcal α-Toxin Promotes Blood Coagulation via Attack on Human Platelets. J Exp Med 168: 527-542, 1988.
12. Susor WA and Rutter WJ: Method for the Detection of Pyruvate Kinase, Aldolase and other Pyridine Nucleotide Linked Enzyme Activities After Electrophoresis. Analyt Biochem 43: 147-155, 1971.
13. Domingo M, Einig C, Eigenbrodt E and Reinacher M: Immunohistological Demonstration of Pyruvate Kinase Isoenzyme Type L in Rat with Monoclonal Antibodies. J Histochem Cytochem 40: 665-673, 1992.
14. Fischer G, Holzrichter S, Reinacher M, Heinrichs M, Dembowski J und Eigenbrodt E: Immunhistochemische Darstellung der L- und M2-Pyruvatkinase in primären Nierenzellkarzinomen und deren Metastasen. Verh Dtsch Ges Path 73: 422-427, 1989.
15. Sturgeon CM: Carcinoembryonic Antigen and Related Glycoproteins as Tumor Markers. Trends Biochem Sci 4: 121-123, 1979.